ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...

Around one in seven adults in the United States have chronic kidney disease (CKD), a condition in which the kidneys become damaged and can’t work as efficiently. This allows waste products to build up ...

Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining on the treatment for the rest of their lives, according to a new study led ...

CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today ...

Subtle abnormalities in kidney function—even within the range considered normal—may help identify people at risk of ...

A less intensive dialysis strategy is feasible for stable patients with acute kidney injury, but warrants further testing. A conservative vs conventional approach to hemodialysis may help ...

Patients with chromophobe RCC are more likely to experience complete recovery of kidney function after radical nephrectomy, and this is associated with better survival. While uncommon, complete ...

A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...